Sequence-Specific 2-Cyanobenzothiazole Ligation

Area of Science:

• Chemical Biology
• Molecular Biology
• Biotechnology

Background:

• Protein labeling is crucial for studying biological processes.
• Current methods often involve harsh conditions or complex catalysts, potentially perturbing protein function.
• There is a need for efficient, catalyst-free bioorthogonal reactions for in-cell protein labeling.

Purpose of the Study:

• To discover a novel peptide tag for site-specific protein labeling.
• To develop a catalyst-free bioorthogonal reaction for labeling proteins in cellular environments.
• To characterize the reactivity and specificity of the newly discovered peptide tag.

Main Methods:

• Screening a cysteine-encoded peptide phage library using the phage-assisted interrogation of reactivity method.
• Engineering a 2-cyanobenzothiazole (CBT)-reactive peptide tag, named CX10R7.
• Fusing CX10R7 with proteins of interest and performing site-specific labeling in vitro and on E. coli cell surfaces.
• Conducting mutagenesis studies to understand the factors influencing tag reactivity and specificity.

Main Results:

• Discovery and characterization of the CX10R7 peptide tag, which reacts with 2-cyanobenzothiazole (CBT).
• Demonstration of site-specific protein labeling using CX10R7-fusion proteins, both in vitro and on the surface of E. coli.
• Identification of the surrounding amino acid sequence as critical for stabilizing the ligation product and ensuring reactivity and specificity.

Conclusions:

• The CX10R7 peptide tag provides a novel, efficient, and catalyst-free method for bioorthogonal protein labeling.
• This approach minimizes perturbation to protein function, making it suitable for cellular applications.
• The findings advance the development of tools for protein engineering and biochemical studies.